Novel Insights and Applications of Pluripotent Stem Cells
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Cellular Biochemistry".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 31
Special Issue Editors
Interests: cell biology; stem cells and differentiation; genome editing; molecular biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), possess the remarkable ability to differentiate into all cell types of the body. These cells provide unparalleled opportunities for studying early human development, modeling human diseases, screening therapeutic compounds, and advancing regenerative medicine. In recent years, pluripotent stem cell-based technologies have transformed our understanding of human biology and opened new avenues for biomedical applications.
This Special Issue will highlight novel insights and applications of pluripotent stem cells, with a focus on the molecular mechanisms governing pluripotency and differentiation, disease modeling using PSC-derived cells, biomolecules associated with PSC function, and emerging applications in biotechnology and medicine. We invite original research articles and comprehensive reviews covering areas such as biomolecular pathways in pluripotency, disease modeling, organoid technologies, cell-based therapies, and PSC-based biomolecule discovery.
We look forward to your contributions to this Special Issue.
Dr. Huseyin Sumer
Dr. Ben N. Rollo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pluripotent stem cells
- pluripotency
- differentiation
- stem cell transplant
- regenerative medicine
- disease modeling
- organoids
- therapeutic screening
- cell therapies
- drug discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
